Jyothy Laboratories has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on May 18, 2017, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2017 and to consider and recommend dividend, if any, on the Equity Shares of the Company for the financial year 2016-17.
The above information is a part of company’s filings submitted to BSE.